Welcome to LookChem.com Sign In|Join Free

CAS

  • or

896139-85-8

Post Buying Request

896139-85-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

896139-85-8 Usage

Chemical Properties

Pale Yellow Solid

Uses

Intermediate for heterocyclic compounds as tyrosine kinase inhibitors and anticancer agents

Check Digit Verification of cas no

The CAS Registry Mumber 896139-85-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,9,6,1,3 and 9 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 896139-85:
(8*8)+(7*9)+(6*6)+(5*1)+(4*3)+(3*9)+(2*8)+(1*5)=228
228 % 10 = 8
So 896139-85-8 is a valid CAS Registry Number.
InChI:InChI=1/C7H6N2O/c10-6-1-3-9-4-2-8-7(9)5-6/h1-5,10H

896139-85-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name Imidazo[1,2-a]pyridin-7-ol

1.2 Other means of identification

Product number -
Other names 1H-imidazo[1,2-a]pyridin-7-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:896139-85-8 SDS

896139-85-8Relevant articles and documents

ErbB RECEPTOR INHIBITORS AS ANTI-TUMOR AGENTS

-

Page/Page column 170; 171, (2021/09/17)

Provided herein are novel compounds as inhibitors of type I receptor tyrosine kinases, the pharmaceutical compositions comprising one or more of the compounds and salts thereof as an active ingredient, and the use of the compounds and salts thereof in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals and especially in humans.

Imidazo[1,2-a]pyridine compound, and preparation method and applications thereof

-

Paragraph 0067; 0069, (2017/08/28)

The invention discloses an imidazo[1,2-a]pyridine compound, and a preparation method and applications thereof. The imidazo[1,2-a]pyridine compound can inhibit the activity of NEK2 kinases as an NEK2 micro-molecular inhibitor with a novel structure. The in

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 896139-85-8